Profile for Japan Patent: 2009530385
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Japan Patent: 2009530385
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| ⤷ Start Trial | Mar 5, 2033 | Janssen Pharms | SPRAVATO | esketamine hydrochloride |
| ⤷ Start Trial | Mar 20, 2027 | Janssen Pharms | SPRAVATO | esketamine hydrochloride |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
